Copanlisib plus rituximab combination therapy vs. rituximab monotherapy for relapsed indolent non-Hodgkin lymphoma: a cost-effectiveness analysis
@article{ATM91911, author = {Xiao Tang and Xudong Chen and Tiantian Zhang and Jie Jiang}, title = {Copanlisib plus rituximab combination therapy vs. rituximab monotherapy for relapsed indolent non-Hodgkin lymphoma: a cost-effectiveness analysis}, journal = {Annals of Translational Medicine}, volume = {10}, number = {6}, year = {2022}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/91911} }